Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer
Conditions
- Chronic Myeloproliferative Disorders
- Graft Versus Host Disease
- Leukemia
- Myelodysplastic Syndromes
- Myelodysplastic/Myeloproliferative Diseases
Interventions
- BIOLOGICAL: anti-thymocyte globulin
- DRUG: busulfan
- DRUG: fludarabine phosphate
- DRUG: methotrexate
- DRUG: tacrolimus
- PROCEDURE: allogeneic hematopoietic stem cell transplantation
- PROCEDURE: peripheral blood stem cell transplantation
Sponsor
Fred Hutchinson Cancer Center
Collaborators